Eagle Pharmaceuticals
EGRX
#11126
Rank
HK$25.8 M
Marketcap
HK$1.96
Share price
0.00%
Change (1 day)
-67.71%
Change (1 year)

EPS for Eagle Pharmaceuticals (EGRX)

EPS in 2023 (TTM): HK$9.31

According to Eagle Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is HK$9.33. In 2022 the company made an earnings per share (EPS) of HK$24.24 an increase over its 2021 EPS that were of -HK$5.18.

EPS history for Eagle Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$9.31-61.58%
2022HK$24.24-568.18%
2021-HK$5.18
2019HK$8.08-52.75%
2018HK$17.10-36.63%
2017HK$26.98-35.09%
2016HK$41.581792.86%
2015HK$2.20-117.39%
2014-HK$12.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.40 461.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.18 341.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$242.32 2,495.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.34 1,360.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.46 279.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.57 141.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$3.53-62.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel